Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study)

Chaudhary Varun; Barbosa Joshua; Lam Wai-Ching; Mak Michael; Mavrikakis Emmanouil; Mohaghegh S. Mohammad P.

首页> 外文期刊>Canadian journal of ophthalmology >Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study)

【24h】

Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study)

机译：Ozurdex与兰尼单抗辅助治疗与年龄相关的黄斑变性（OARA研究）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To evaluate the utility of dexamethasone intravitreal implant (DXI; Ozurdex; Allergan, Irvine, Calif.) in combination with ranibizumab (Lucentis; Novartis Pharma AG, Basel, Switzerland) versus ranibizumab monotherapy on visual acuity (VA) and anatomical outcomes in a neovascular age-related macular degeneration (nAMD) cohort.

机译：目的：评估地塞米松玻璃体内植入物（DXI; Ozurdex;艾尔根，欧文，加利福尼亚）与兰尼单抗（Lucentis;诺华制药公司，瑞士巴塞尔，瑞士）联合使用兰尼单抗单药治疗的视力（VA）和解剖结果新血管性年龄相关性黄斑变性（nAMD）队列。

著录项

来源
《Canadian journal of ophthalmology》 |2016年第4期|共4页
作者
Chaudhary Varun; Barbosa Joshua; Lam Wai-Ching; Mak Michael; Mavrikakis Emmanouil; Mohaghegh S. Mohammad P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
入库时间 2022-08-18 09:14:54

相似文献

外文文献
中文文献
专利

1. Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study) [J] . Chaudhary Varun, Barbosa Joshua, Lam Wai-Ching, Canadian journal of ophthalmology . 2016,第4期

机译：Ozurdex与兰尼单抗辅助治疗与年龄相关的黄斑变性（OARA研究）
2. Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration [J] . Elman Michael J., Brown David M., Kaiser Peter K., Investigative ophthalmology & visual science . 2018,第9期

机译：与Ranibizimab双药草的治疗幼鱼乳蛋白单疗法与Ranibizimab与ranibizimab与Ranibizimab单疗法相比，与Ranibizimab的单一治疗与Ranibizimab双胍溶解的临床研究与Ranibizimab Ophthalmic溶液相比，与Ranibizimab的治疗中的治疗中的幼苗单一治疗相比，临床研究与Ranibizimizumab相比。退化
3. Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life [J] . Cazet-Supervielle Agathe, Gozlan Julien, Cabasson Severin, Ophthalmologica: International Journal of Ophthalmology=Journal International d'Ophtalmologie . 2015,第1期

机译：玻璃体内雷珠单抗在年龄相关性黄斑变性的每日临床实践中：治疗渗出性年龄相关性黄斑变性的现实生活
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid 30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study) [O] . A T Fung, N Kumar, S K Vance, 2012

机译：评价玻璃体腔内抗VEGF治疗后持续/复发黄斑积液30天的患者中大剂量rAnibizumab2.0μmg在新生血管性黄斑变性管理中的作用的初步研究（LAST研究）
7. Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial [O] . Kuppermann Baruch D., Goldstein Michaella, Maturi Raj K., 2015

机译：地塞米松玻璃体内植入作为Ranibizumab在新血管性年龄相关性黄斑变性中的辅助治疗：多中心随机对照试验

Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study)

摘要

著录项

相似文献

相关主题

期刊订阅